Skip to main content

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Call For Papers

Broadly protective anti-viral vaccines

This thematic series welcomes articles exploring recent developments and promising new research avenues for the development of broadly protective anti-viral vaccines, as well as hurdles and limitations. Studies considering aspects of health economics and health services are also in scope in this series, including research funding, international cooperation, and global investment for better pandemic preparedness. Currently open for submissions - Submit Here

Coronaviruses: emerging and re-emerging pathogens in humans and animals

This thematic series emphasizes advances and key discoveries in the animal origin, viral evolution, epidemiology, diagnostics and pathogenesis of different emerging and re-emerging coronaviruses. Currently open for submissions - Submit Here 


Edited by Susanna K. P. Lau, Hayes Luk, Siddharth Sridhar, and Linfa Wang

Viruses as targets and vectors

The field of gene therapy for viral infections and use of viruses to deliver therapeutic sequences is now poised at an interesting phase. This series, themed on targeting viruses and use of recombinant viruses as vectors, reports on significant developments and challenges in this exciting field. Currently open for submissions - Submit Here


Edited by Prof Patrick Arbuthnot

Contribution of climate change to the spread of infectious diseases

This cross-journal collection brings together in one place articles outlining those diseases (and their vectors) that are likely to spread or are already spreading across borders due to the effects of climate change. Currently open for submissions - Submit Here

Articles

  1. Authors: Abdulrahim R. Hakami, Abdullah A. Alshamrani, Mohamad Alqahtani, Yasser Alraey, Razan A. Alhefzi, Sultan Alasmari, Mohamed Makkawi, Gasim Dobie, Mushtaq Mir, Mohamed Alshahrani, Ayed Dera, Mohammed Alfaifi, Mesfer Al Shahrani, Ahmad Matari and Ali Essa Asiry

    Content type: Research

Sign up to receive article alerts

Virology Journal is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

SARS-CoV-2 and COVID-19

Find a selection of articles published across Springer Nature, as well as additional commentary and books relevant to SARS-CoV-2 and COVID-19 research.

Read more

Article collections

Discover all the article collections published in Virology Journal. Find out more

Aims and scope

Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.

Read more

Why publish your article in Virology Journal?

  • Edited by leading virologists, our journal brings together all areas of virology research.
  • With more than 100,000 monthly accesses, we ensure exceptional visibility and community attention for your work.
  • We welcome basic research, as well as pre-clinical and clinical studies, and research on vaccines and anti-viral therapies.
  • We deliver high levels of author satisfaction, with 93% of our published authors reporting that they would definitely or probably publish with us again.

Journal Sections

Clinical Virology: Fred Kibenge, University of Prince Edward Island, Canada 
Emerging viruses: Tom Geisbert, University of Texas Medical Branch, USA
Hepatitis viruses: Alan McLachlan, University of Illinois at Chicago, USA
Herpes viruses: Blossom Damania, University of North Carolina at Chapel Hill, USA
Influenza viruses: Hualan Chen, Chinese Academy of Agricultural Sciences, China
Negative-strand RNA viruses: Bert Rima, Queen’s University Belfast, UK
Other viruses: Erna Geessien Kroon, Universidade Federal de Minas Gerais, Brazil
Plant viruses: Chikara Masuta, Hokkaido University, Japan
Positive-strand RNA viruses: Jason Mackenzie, The University of Melbourne, Australia
Retroviruses: Linda Chelico, University of Saskatchewan, Canada
Veterinary DNA viruses: Gerlinde Van de Walle, Cornell University, USA
Veterinary RNA viruses: Siba Samal, University of Maryland, USA
Viruses of microbes: Joana Azeredo, University of Minho, Portugal

Announcing the launch of In Review

Virology Journal, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Linfa Wang, Editor-in-Chief

Prof Wang is the director of the Programme in Emerging Infectious Diseases at Duke-NUS Medical School, and an honorary professor at the University of Melbourne and the Chinese Academy of Sciences. He is an international leader in the field of emerging zoonotic viruses and virus-host interaction, specialising in bat-borne viruses. After completing his Bachelor's degree in 1982 at the East China Normal University, he went on to obtain his PhD at the University of California, Davis. In 1990, he joined the CSIRO, Australian Animal Health Laboratory where he played a leading role in identifying bats as the natural host of the Severe Acute Respiratory Syndrome (SARS) virus. 

Prof Wang's work has been recognized internationally through various international awards, numerous invited speeches at major international conferences, many top scientific publications, five patents and many invited book chapters. He holds a number of honorary positions and memberships and has received numerous awards such as the 2014 Eureka Prize for Research in Infectious Diseases. In 2010, Prof Wang was elected as a Fellow of Australian Academy of Technological Sciences and Engineering in recognition of his expertise in new and emerging diseases.

Annual Journal Metrics